Prognostic criteria for experimental protocols in pediatric brainstem gliomas

Area of Science:

• Pediatric Oncology
• Radiation Oncology
• Neuro-Oncology

Background:

• Brainstem gliomas are aggressive pediatric tumors with poor prognoses.
• Identifying high-risk patients is crucial for selecting appropriate treatment strategies.
• Current prognostic methods may involve invasive procedures.

Purpose of the Study:

• To develop and validate noninvasive prognostic criteria for selecting children with high-risk brainstem gliomas.
• To identify patients suitable for experimental hyperfractionated radiation therapy.
• To avoid unnecessary biopsies in prognostic assessments.

Main Methods:

• Development of criteria based on tumor location (brainstem), neurological signs (cranial nerve, long-tract, cerebellar), and symptom duration (<6 months).
• Application of these criteria to a cohort of children with brainstem gliomas.
• Evaluation of 18-month survival rates in the selected patient group.

Main Results:

• The developed criteria identified patients with tumors confined to the brainstem and specific neurological deficits.
• A short symptom duration (<6 months) was a key factor.
• Only 1 out of 33 evaluable patients survived at 18 months, indicating successful selection of a poor-prognosis group.

Conclusions:

• The established noninvasive criteria effectively select children with high-risk brainstem gliomas.
• These criteria facilitate the selection of patients for experimental therapies when standard treatments are unlikely to be beneficial.
• The criteria avoid the need for routine biopsies, reducing patient risk.